75 citations · 147 across the 9 of their papers we have counts for
9 papers
ICPR 2024 Competition on Multiple Sclerosis Lesion Segmentation -- Methods and Results
Alessia Rondinella, Francesco Guarnera, Elena Crispino +5
This report summarizes the outcomes of the ICPR 2024 Competition on Multiple Sclerosis Lesion Segmentation (MSLesSeg). The competition aimed to develop methods capable of automatic…
Boosting multiple sclerosis lesion segmentation through attention mechanism
Alessia Rondinella, Elena Crispino, Francesco Guarnera +7
Magnetic resonance imaging is a fundamental tool to reach a diagnosis of multiple sclerosis and monitoring its progression. Although several attempts have been made to segment mult…
Possible Contexts of Use for In Silico trials methodologies: a consensus-based review
Marco Viceconti, Luca Emili, Payman Afshari +15
The term "In Silico Trial" indicates the use of computer modelling and simulation to evaluate the safety and efficacy of a medical product, whether a drug, a medical device, a diag…
Verification of an agent-based disease model of human mycobacterium tuberculosis infection
Cristina Curreli, Francesco Pappalardo, Giulia Russo +5
Agent-Based Models are a powerful class of computational models widely used to simulate complex phenomena in many different application areas. However, one of the most critical asp…
In Silico Trial to test COVID-19 candidate vaccines: a case study with UISS platform
Giulia Russo, Marzio Pennisi, Marco Viceconti +1
SARS-CoV-2 is a severe respiratory infection that infects humans. Its outburst entitled it as a pandemic emergence. To get a grip on this, outbreak specific preventive and therapeu…
Generation of digital patients for the simulation of tuberculosis with UISS-TB
Marzio Pennisi, Miguel A. Juarez, Giulia Russo +2
EC funded STriTuVaD project aims to test, through a phase IIb clinical trial, two of the most advanced therapeutic vaccines against tuberculosis. In parallel, we have extended the…